WBB Securities Asset Management Receives Hedgeweek Award For Life Sciences Investing
Posted: Sep 22nd, 2017In: Press ReleasesWBB Securities, LLC is pleased to announce that the WBB Asset Management Long/Short Life Science Strategy (LSLSS) was the recipient of Hedgeweek USA’s 2017 Award for Best Event Driven Strategy last night in New York[...]
Read More about WBB Securities Asset Management Receives Hedgeweek Award For Life Sciences InvestingWBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 Biosystems
Posted: Sep 21st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.
Read More about WBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 BiosystemsWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 8th, 2017In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.
Posted: May 31st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.
Read More about WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.WBB Securities Sponsors BioCentury’s 2017 Future Leaders Conference
Posted: Apr 7th, 2017In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2017 Future Leaders ConferenceWBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit Facility
Posted: Jan 5th, 2017In: Press ReleasesWBB Securities acted as financial advisor to T2 Biosystems, Inc., a manufacturer of next generation diagnostic equipment, for a credit facility up to $50 million.
Read More about WBB Securities Acts as Financial Advisor to T2 Biosystems for $50 Million Credit FacilityWBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta Therapeutics
Posted: Sep 29th, 2016In: Press ReleasesWBB Securities acted as co-manager to a transaction for Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics.
Read More about WBB Securities Acts as Co-Manager for $300 Million Public Offering for Sarepta TherapeuticsJohn Nolan Joins WBB to Head Asset Management Team
Posted: Sep 2nd, 2016In: Press ReleasesWBB Securities, a leading investment management, investment banking, and equity research firm, announced today that John Nolan has joined the firm as Managing Director of WBB Asset Management where he will also serve as a[...]
Read More about John Nolan Joins WBB to Head Asset Management TeamWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 1st, 2016In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference
Posted: Mar 1st, 2016In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2016 Future Leaders Conference